CT UK High Income Trust Provides Portfolio Update
Why we think this is good
The RNS provides a routine portfolio update for the CT UK High Income Trust, detailing the top 10 holdings and investment breakdown. While the information is useful for investors, there are no significant positive or negative developments reported that would warrant a higher or lower sentiment score. The update appears to be in line with market expectations.
Key Points
- Portfolio update as of 31 March 2025
- Top 10 holdings include HSBC, Shell, AstraZeneca, Unilever
- Investment breakdown: 81.52% FTSE 100, 12.76% FTSE 250, 3.38% non-index, 1.65% overseas, 0.69% AIM
- Net gearing of 5.26%
Summary
The investment trust has provided an update on its portfolio, including the top holdings and asset allocation. The information appears to be in line with market expectations.
The CT UK High Income Trust has released a portfolio update as of 31 March 2025. The top 10 holdings include major UK companies such as HSBC, Shell, AstraZeneca, and Unilever. The investment breakdown shows the portfolio is predominantly invested in FTSE 100 companies, with smaller allocations to FTSE 250, non-index, overseas, and AIM stocks. The trust's net gearing is 5.26%.
GENERAL UPDATE